<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Sequence variants of angiotensin converting enzyme (ACE) insertion/deletion (I/D), angiotensinogen (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AGT</z:e>) T235M, <z:chebi fb="0" ids="2719,48432">angiotensin II</z:chebi> type 1 receptor (AT1R) A1166C, and plasminogen activator inhibitor-1 (PAI-1) 4G/5G were analyzed to see their genetic associations with vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> as its candidate genetic risk factors involving renin-angiotensin and fibrin systems </plain></SENT>
<SENT sid="1" pm="."><plain>While the ACE I/D, AT1R A1166C, and PAI-1 4G/5G did not contribute to the genetic susceptibility to vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (P&gt;0.05), a significant association with vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> was shown in the T235M polymorphism of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AGT</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The frequency of the M allele in patients was higher than in controls with the odds ratio (OR) estimate of 1.51 (P&lt;0.05) </plain></SENT>
<SENT sid="3" pm="."><plain>In a dominant model, the TM+MM genotypes increased the risk of vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> compared to the TT genotype (OR=2.01; P&lt;0.001) </plain></SENT>
<SENT sid="4" pm="."><plain>The current results suggested that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AGT</z:e> T235M polymorphism might be a risk factor of vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
</text></document>